Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Depress Anxiety. 2019 Apr 17;36(7):617–624. doi: 10.1002/da.22897

Table 1.

Sample Characteristics

Total sample Active Placebo

Variable M (SD) M (SD) M (SD)
Age 44.93 (11.83) 40.89 (9.36) 51.00 (13.33)
Adherence: days initiated treatment 21.5 (6.1) 19.67 (5.81) 24.17 (6.01)
Adherence: minutes per treatment day in prescribed window 35.2 (6.3) 32.45 (5.30) 39.22 (5.81)
Variable n (%) n (%) n (%)

Male 7 (46.7) 5 (55.6) 2 (33.3)
Ethnicity
  Non-Hispanic 11 (73.3) 6 (66.7) 5 (83.3)
  Hispanic / Latino 4 (26.7) 3 (33.3) 1 (16.7)
Race
  White 4 (26.7) 4 (44.4) 0 (0.0)
  Black / African American 8 (53.3) 3 (33.3) 5 (83.3)
  Mixed 2 (13.3) 1 (11.1) 1 (16.7)
  Decline to answer 1 (6.7) 1 (11.1) 0 (0.0)
Marital Status
  Single 12 (80.0) 7 (77.8) 5 (83.3)
  Married / domestic partnership / engaged 3 (20.0) 2 (22.2) 1 (16.7)
Highest Degree
  Less than high school 2 (13.3) 2 (22.2) 0 (0.0)
  High school / GED 4 (26.7) 1 (11.1) 3 (50.0)
  Vocational / Associates Degree / Some college 6 (40.0) 5 (55.5) 1 (16.7)
  Baccalaureate or Master’s degree 3 (20.0) 1 (11.1) 2 (33.3)
Index trauma type
  Physical / Sexual assault 5 (33.3) 2 (22.2) 3 (50.0)
  Being shot / Shot at 4 (26.7) 4 (44.4) 0 (0.0)
  Witnessing serious harm or death of others 3 (20.0) 2 (22.2) 1 (16.7)
  Combat 2 (13.3) 1 (11.1) 1 (16.7)
  Motor vehicle accident 1 (6.7) 0 (0.0) 1 (16.7)

Note. Total sample N = 14. Active group n = 9. Placebo group n = 6. “Adherence: days initiated treatment” refers to the number of days that participants completed part or all of the morning light treatment out of the 28 treatment days. “Adherence: minutes per treatment day in prescribed window” refers to the minutes of light that participants received in the treatment window on days when they initiated treatment.